W. Jeff Petty, MD
Associate Professor, Hematology and Oncology
Petty's research focuses on two distinct but convergent signaling pathways: the epidermal growth factor receptor (EGFR) pathway and the retinoic acid receptor (RAR) pathway. By understanding mechanisms of response or resistance to drugs that target these pathways, he hopes to develop effective chemoprevention strategies that could be used to treat early stage lung carcinogenesis.
Keywordscancer, leukemia, hematology, oncology, lung cancer, clinical pharmacology, anticancer drugs, radiation oncology, thoracic surgery, inpatient solid tumor service, medical oncology clinic, thoracic oncology program